Many subsequent whole-exome and targeted sequencing studies of CRC and EC samples similarly reported somatic POLE mutations, together revealing that at least 6% of colorectal and 7% of endometrial tumors contain these changes (Barbari and Shcherbakova 2017). Here, POLE is linked to colorectal carcinoma.